1. Home
  2. ICAD vs VERU Comparison

ICAD vs VERU Comparison

Compare ICAD & VERU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ICAD
  • VERU
  • Stock Information
  • Founded
  • ICAD 1984
  • VERU 1971
  • Country
  • ICAD United States
  • VERU United States
  • Employees
  • ICAD N/A
  • VERU N/A
  • Industry
  • ICAD Medical/Dental Instruments
  • VERU Biotechnology: Pharmaceutical Preparations
  • Sector
  • ICAD Health Care
  • VERU Health Care
  • Exchange
  • ICAD Nasdaq
  • VERU Nasdaq
  • Market Cap
  • ICAD 87.5M
  • VERU N/A
  • IPO Year
  • ICAD 1986
  • VERU 1990
  • Fundamental
  • Price
  • ICAD $2.03
  • VERU $0.49
  • Analyst Decision
  • ICAD
  • VERU Strong Buy
  • Analyst Count
  • ICAD 0
  • VERU 4
  • Target Price
  • ICAD N/A
  • VERU $4.00
  • AVG Volume (30 Days)
  • ICAD 270.6K
  • VERU 1.2M
  • Earning Date
  • ICAD 03-19-2025
  • VERU 05-07-2025
  • Dividend Yield
  • ICAD N/A
  • VERU N/A
  • EPS Growth
  • ICAD N/A
  • VERU N/A
  • EPS
  • ICAD N/A
  • VERU N/A
  • Revenue
  • ICAD $19,608,000.00
  • VERU $16,886,419.00
  • Revenue This Year
  • ICAD $2.39
  • VERU N/A
  • Revenue Next Year
  • ICAD $13.71
  • VERU N/A
  • P/E Ratio
  • ICAD N/A
  • VERU N/A
  • Revenue Growth
  • ICAD 13.22
  • VERU 22.46
  • 52 Week Low
  • ICAD $1.18
  • VERU $0.45
  • 52 Week High
  • ICAD $3.78
  • VERU $1.92
  • Technical
  • Relative Strength Index (RSI)
  • ICAD 38.33
  • VERU 43.48
  • Support Level
  • ICAD $2.05
  • VERU $0.50
  • Resistance Level
  • ICAD $2.48
  • VERU $0.57
  • Average True Range (ATR)
  • ICAD 0.16
  • VERU 0.03
  • MACD
  • ICAD -0.00
  • VERU 0.01
  • Stochastic Oscillator
  • ICAD 8.33
  • VERU 33.42

About ICAD iCAD Inc.

icad Inc is a medical technology company providing cancer detection and therapy solutions. The Company operates in one segment: Detection. The Detection segment include advanced image analysis and workflow solutions that enable healthcare professionals to serve patients by identifying pathologies, comprehensive range of high-performance, Artificial Intelligence and Computer-Aided Detection (CAD) systems and workflow solutions for 2D and 3D mammography, Magnetic Resonance Imaging and Computed Tomography. The company geographically operates in France, Belgium, Italy, Germany, Switzerland and All other.

Share on Social Networks: